Nevro Files Lawsuit for Patent Infringement Against Stimwave in the U.S.

REDWOOD CITY, Calif., Feb. 15, 2019 -- (Healthcare Sales & Marketing Network) -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has... Devices, Litigation Nevro Corp, Stimwave Technologies, Senza system, HF10 therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news